Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Bioinformatics Market Potential

Vaccine Research & Development 2009

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

New Products

Advanced Wound Management Pipeline Technology and Market Forecasts to 2015

Artificial Disc Replacement Pipeline Technology and Market Forecasts to 2015

Brazil Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Brazil Orthopedic Devices Market Analysis and Forecasts to 2015

Canada Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Canada Diabetes Care Devices Market Analysis and Forecasts to 2015

Canada Medical Equipment Market Analysis and Forecasts to 2015

Cardiac Assist Devices Pipeline Technology and Market Forecasts to 2015

China Medical Equipment Market Analysis and Forecasts to 2015

Chronic Diseases on the Rise: Personal Health Systems to Play a Key Role in Disease Management

BioPortfolio | CuttingEdgeInfo Reports | Securing Market Access (PH129) Reimbursement, Payer Relationships and Healthcare Reform

Securing Market Access (PH129) Reimbursement, Payer Relationships and Healthcare Reform

Strengthen payer relationships through communication:

Of all factors contributing to product success, payer access could be the most critical. Without the best reimbursement status for a drug, the investments your company made during drug development may end up as a lost cause. Securing Market Access: Reimbursement, Payer Relationships and Healthcare Reform examines the processes, strategies and best practices that industry leaders have implemented to build strong relationships and gain payer access.

This report is a tool for companies to adjust their strategies to meet growing payer demands and facilitate the reimbursement process:

Improve payer communication and formulary submission success.

Metrics on payer targeting, communication methods and timing guide the strategic recommendations leading to healthier and more lucrative relationships for pharmaceutical companies with payers.

Increase the efficiency of your managed market department:

Analyze benchmarking data from surveyed companies on organizational structure, headcount distribution for various functions within the managed markets group, account distribution and resource allocation.

Understand the impact of potential healthcare reform on managed markets teams

Although there are no clear-cut solutions to healthcare reform, this report provides recommendations for drug companies to prepare for both minor and major changes to the healthcare system. Interviewed pharmaceutical executives discuss their strategic responses to potential changes that could be on the managed markets horizon. Cutting Edge Information's analysts designed the practices contained within to help managed markets teams develop strategies to respond effectively to various scenarios that could emerge.

Companies Included in Report

* Acorda Therapeutics

* Allergan

* Amicus Therapeutics

* Axcan Pharma

* Boehringer Ingelheim

* Genzyme

* Grunenthal

* GlaxoSmithKline

* Janssen-Cilag

* Lundbeck

* MAP Pharmaceuticals

* Merck

* Merck Serono

* Novo Nordisk

* Pfizer

* Quintiles

* Roche

* United Therapeutics

* Wyeth

* ...plus more

Published 2009

123 Pages

350+ Metrics

20 Companies
Table of Contents
Price: $7,685.00 / €5,136.65

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions